Laborie Medical Technologies

May 08, 2025

Three-Year Data from ROBUST III Confirms Long-Term Durability of Optilume® Drug-Coated Balloon for Recurrent Urethral Strictures

Jan 17, 2025

Optilume Drug-Coated Balloon Shows Long-Term Efficacy for Urethral Strictures: Five-Year Data Published in the Journal of Urology

Oct 28, 2024

Optilume® BPH Catheter System Issued Category 1 CPT Code by American Medical Association

Jul 17, 2024

Laborie Medical Technologies Invests in Medical Technology Start-Up Novocuff

May 20, 2024

Laborie Introduces Solar Compact System and Solar Anorectal Manometry Catheter for Enhanced Gastrointestinal Diagnostics

May 13, 2024

Laborie Unveils Positive Study Results for Optilume® BPH Catheter System

Apr 30, 2024

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

Mar 29, 2024

Laborie Medical Technologies Invests in iO Urology and the CarePath Uroflow Device

Jan 08, 2024

Laborie Introduces the Next Generation RenovaRP Centesis System